TIAA CREF Investment Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $10.2M | Sell |
750,772
-644,837
| -46% | -$8.8M | 0.01% | 1029 |
|
|
2018
Q4 | $14.3M | Buy |
1,395,609
+346,476
| +33% | +$3.55M | 0.01% | 791 |
|
|
2018
Q3 | $17.5M | Buy |
1,049,133
+925,463
| +748% | +$15.4M | 0.01% | 795 |
|
|
2018
Q2 | $1.95M | Sell |
123,670
-51,620
| -29% | -$816K | ﹤0.01% | 2188 |
|
|
2018
Q1 | $2.23M | Sell |
175,290
-219,299
| -56% | -$2.78M | ﹤0.01% | 2045 |
|
|
2017
Q4 | $4.52M | Buy |
394,589
+229,010
| +138% | +$2.62M | ﹤0.01% | 1665 |
|
|
2017
Q3 | $2.03M | Buy |
165,579
+235
| +0.1% | +$2.88K | ﹤0.01% | 2158 |
|
|
2017
Q2 | $1.89M | Buy |
165,344
+22,277
| +16% | +$255K | ﹤0.01% | 2215 |
|
|
2017
Q1 | $2.98M | Sell |
143,067
-6,889
| -5% | -$143K | ﹤0.01% | 1905 |
|
|
2016
Q4 | $3.12M | Buy |
149,956
+8,744
| +6% | +$182K | ﹤0.01% | 1928 |
|
|
2016
Q3 | $4.63K | Sell |
141,212
-2,728
| -2% | -$89 | ﹤0.01% | 1660 |
|
|
2016
Q2 | $3.59M | Buy |
143,940
+74,036
| +106% | +$1.85M | ﹤0.01% | 1768 |
|
|
2016
Q1 | $1.71M | Sell |
69,904
-3,897
| -5% | -$95.4K | ﹤0.01% | 2169 |
|
|
2015
Q4 | $2.44M | Hold |
73,801
| – | – | ﹤0.01% | 2027 |
|
|
2015
Q3 | $2.42M | Buy |
73,801
+3,778
| +5% | +$124K | ﹤0.01% | 2032 |
|
|
2015
Q2 | $3.71M | Buy |
70,023
+36,450
| +109% | +$1.93M | ﹤0.01% | 1899 |
|
|
2015
Q1 | $969K | Buy |
33,573
+5,033
| +18% | +$145K | ﹤0.01% | 2637 |
|
|
2014
Q4 | $830K | Sell |
28,540
-5,044
| -15% | -$147K | ﹤0.01% | 2756 |
|
|
2014
Q3 | $426K | Buy |
33,584
+2,780
| +9% | +$35.3K | ﹤0.01% | 3010 |
|
|
2014
Q2 | $618K | Buy |
+30,804
| New | +$618K | ﹤0.01% | 2956 |
|